www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Sigma_aldrich Logo
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > Product Search > Laropiprant | 571170-77-9
english deutsch español

Suppliers for CAS

571170-77-9

Properties

CAS   571170-77-9 
Formula   C21H19ClFNO4S 

Structure

10 Registered suppliers

Dayang Chem (Hangzhou) Co.,Ltd. P.R.China
rd Laropiprant  
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) P.R.China
rd Laropiprant  
Leap Chem Co., Ltd P.R.China
rd MK 0524   CD details
Chemvon Biotechnology Co. Ltd. P.R.China
rd Laropiprant  
Molecular Formula: C21H19ClFNO4S
Molecular Weight: 435.901
Aea.ltd P.R.China
rd MK 0524  
Molecular Formula: C21H19ClFNO4S
Molecular Weight: 435.901
Hangzhou Zhongqi Chem Co., Ltd P.R.China
rd Laropiprant  
Molecular Formula: C21H19ClFNO4S
Molecular Weight: 435.901
BOC Sciences USA
rd Laropiprant   CD details
Chemos GmbH & Co. KG Germany
rd Laropiprant  
Description :
a drug used in combination with niacin to reduce blood cholesterol (LDL and VLDL) that is no longer sold
  • Molecular Weight :435.91
  • Melting Point :175°C
  • Purity :> 95%
Molecular Formula :
C21H19ClFNO4S
Canonical SMILES :
CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)C(CC3)CC(=O)O
InChI :
1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1
InChIKey :
NXFFJDQHYLNEJK-CYBMUJFWSA-N
Solubility :
Soluble in DMSO
Appearance :
A crystalline solid
Application :
A potent, selective DP1 receptor antagonist
Storage : Store at -20 °C
Synonyms :
(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-cyclopent[b]indole-3-acetic acid
More details are to be found here
CM Fine Chemicals Switzerland
rd (3R)-4-[(4-Chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-cyclopent[b]indole-3-acetic acid  
Description :
a drug used in combination with niacin to reduce blood cholesterol (LDL and VLDL) that is no longer sold
  • Molecular Weight :435.91
  • Melting Point :175°C
  • Purity :> 95%
Molecular Formula :
C21H19ClFNO4S
Canonical SMILES :
CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)C(CC3)CC(=O)O
InChI :
1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1
InChIKey :
NXFFJDQHYLNEJK-CYBMUJFWSA-N
Solubility :
Soluble in DMSO
Appearance :
A crystalline solid
Application :
A potent, selective DP1 receptor antagonist
Storage : Store at -20 °C
Synonyms :
(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-cyclopent[b]indole-3-acetic acid
More details are to be found here
Santa Cruz Biotechnology, Inc. USA
rd MK 0524  
Description :
a drug used in combination with niacin to reduce blood cholesterol (LDL and VLDL) that is no longer sold
  • Molecular Weight :435.91
  • Melting Point :175°C
  • Purity :> 95%
Molecular Formula :
C21H19ClFNO4S
Canonical SMILES :
CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)C(CC3)CC(=O)O
InChI :
1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1
InChIKey :
NXFFJDQHYLNEJK-CYBMUJFWSA-N
Solubility :
Soluble in DMSO
Appearance :
A crystalline solid
Application :
A potent, selective DP1 receptor antagonist
Storage : Store at -20 °C
Synonyms :
(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-cyclopent[b]indole-3-acetic acid
More details are to be found here
Detailed information on the suppliers of Laropiprant

Properties:

... more properties and specification on Laropiprant
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved